Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Igor Bilinsky Insider Profile
4 Followers
Igor Bilinsky, Sr VP, Corporate Development at Fresh Tracks Therapeutics, holds 193.80K shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds ― shares in Tecogen (Ticker: TGEN), holds ― shares in Oncternal Therapeutics (Ticker: ONCT).
Igor Bilinsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Igor Bilinsky holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 14, 2014 - Jan 14, 2015
Return:-26.40%
The most profitable trade made by Igor Bilinsky
Igor Bilinsky's Trading History
Fresh Tracks Therapeutics
Jul 15, 2015
Sr VP, Corporate Development
Uninformative Sell
868.02
$143.41K
Tecogen
―
Chief Operating Officer
―
―
Oncternal Therapeutics
―
―
―
―
Iovance Biotherapeutics
Dec 04, 2024
COO
Uninformative Buy
15.71K
$424.64K
Ignyta Inc
Jan 11, 2016
―
Uninformative Buy
―
$187.57K
List of latest transactions for each holding click on a transaction to see Igor Bilinsky's performance on stock
You May Also Like
Igor Bilinsky insider profile FAQ
What is the percentage of profitable transactions made by Igor Bilinsky?
The percentage of profitable transactions made by Igor Bilinsky is ―.
What is the average return per transaction made by Igor Bilinsky?
The average return per transaction made by Igor Bilinsky is ―.
What stocks does Igor Bilinsky hold?
Igor Bilinsky holds: FRTX, TGEN, ONCT, IOVA, ~RXDX stocks.
What was Igor Bilinsky’s latest transaction?
Igor Bilinsky latest transaction was an Uninformative Sell of $868.02.
What was Igor Bilinsky's most profitable transaction?
Igor Bilinsky’s most profitable transaction was an Informative Buy of FRTX stock on January 14, 2014. The return on the trade was -26.40%.
What is Igor Bilinsky's role in Fresh Tracks Therapeutics?
Igor Bilinsky's role in Fresh Tracks Therapeutics is Sr VP, Corporate Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.